S&P 500   3,273.94 (+1.14%)
DOW   27,059.92 (+1.11%)
QQQ   267.47 (+1.25%)
AAPL   109.49 (+2.21%)
MSFT   205.02 (+2.21%)
FB   250.40 (+0.55%)
GOOGL   1,427.08 (+1.26%)
AMZN   3,048.78 (+1.63%)
NVDA   500.40 (+3.19%)
TSLA   396.07 (+4.13%)
BABA   269.81 (-1.15%)
CGC   14.44 (-1.10%)
GE   6.13 (+0.33%)
MU   49.95 (+0.20%)
AMD   76.74 (+2.69%)
T   28.11 (+0.86%)
F   6.68 (+0.60%)
ACB   5.20 (+0.58%)
GILD   62.20 (-1.41%)
NFLX   473.88 (+0.69%)
DIS   123.16 (-0.10%)
BAC   23.64 (+1.63%)
BA   147.25 (-2.60%)
S&P 500   3,273.94 (+1.14%)
DOW   27,059.92 (+1.11%)
QQQ   267.47 (+1.25%)
AAPL   109.49 (+2.21%)
MSFT   205.02 (+2.21%)
FB   250.40 (+0.55%)
GOOGL   1,427.08 (+1.26%)
AMZN   3,048.78 (+1.63%)
NVDA   500.40 (+3.19%)
TSLA   396.07 (+4.13%)
BABA   269.81 (-1.15%)
CGC   14.44 (-1.10%)
GE   6.13 (+0.33%)
MU   49.95 (+0.20%)
AMD   76.74 (+2.69%)
T   28.11 (+0.86%)
F   6.68 (+0.60%)
ACB   5.20 (+0.58%)
GILD   62.20 (-1.41%)
NFLX   473.88 (+0.69%)
DIS   123.16 (-0.10%)
BAC   23.64 (+1.63%)
BA   147.25 (-2.60%)
S&P 500   3,273.94 (+1.14%)
DOW   27,059.92 (+1.11%)
QQQ   267.47 (+1.25%)
AAPL   109.49 (+2.21%)
MSFT   205.02 (+2.21%)
FB   250.40 (+0.55%)
GOOGL   1,427.08 (+1.26%)
AMZN   3,048.78 (+1.63%)
NVDA   500.40 (+3.19%)
TSLA   396.07 (+4.13%)
BABA   269.81 (-1.15%)
CGC   14.44 (-1.10%)
GE   6.13 (+0.33%)
MU   49.95 (+0.20%)
AMD   76.74 (+2.69%)
T   28.11 (+0.86%)
F   6.68 (+0.60%)
ACB   5.20 (+0.58%)
GILD   62.20 (-1.41%)
NFLX   473.88 (+0.69%)
DIS   123.16 (-0.10%)
BAC   23.64 (+1.63%)
BA   147.25 (-2.60%)
S&P 500   3,273.94 (+1.14%)
DOW   27,059.92 (+1.11%)
QQQ   267.47 (+1.25%)
AAPL   109.49 (+2.21%)
MSFT   205.02 (+2.21%)
FB   250.40 (+0.55%)
GOOGL   1,427.08 (+1.26%)
AMZN   3,048.78 (+1.63%)
NVDA   500.40 (+3.19%)
TSLA   396.07 (+4.13%)
BABA   269.81 (-1.15%)
CGC   14.44 (-1.10%)
GE   6.13 (+0.33%)
MU   49.95 (+0.20%)
AMD   76.74 (+2.69%)
T   28.11 (+0.86%)
F   6.68 (+0.60%)
ACB   5.20 (+0.58%)
GILD   62.20 (-1.41%)
NFLX   473.88 (+0.69%)
DIS   123.16 (-0.10%)
BAC   23.64 (+1.63%)
BA   147.25 (-2.60%)
Log in
CVE:APO

ACASTI PHARM-TS Price Target, Predictions & Analyst Ratings

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

ACASTI PHARM-TS (CVE:APO) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for ACASTI PHARM-TS in the last 12 months. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
APO Consensus Rating: HoldBuyBuyBuy
APO Consensus Rating Score: 2.003.002.502.50
APO Analyst Ratings: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
APO Consensus Price Target: N/AN/AN/AN/A
APO Price Target Upside: N/AN/AN/AN/A

ACASTI PHARM-TS (CVE:APO) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ACASTI PHARM-TS (CVE:APO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
8/31/2020B. RileyDowngradeBuy ➝ Neutral
6/26/2019HC WainwrightReiterated RatingBuy
(Data available from 9/24/2018 forward)
This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.